OHSU Knight Cancer Institute at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

OHSU Knight Cancer Institute brings 5 presentations to AMP 2026 in Seattle. Its program sits on the technical side of the meeting, covering methylation profiling, long-read sequencing in the clinic and innovation led by laboratory technologists. The long-read work looks at how the technology is being put to clinical use.

Organization

AMP 2026 Attendance

OHSU Knight Cancer Institute

Portland, OR

Med centres

Cancer center of Oregon Health & Science University, with clinical molecular diagnostics laboratories.

Session

Thu, Nov 12
2:30pm–3:30pm

Platform Presentations of Selected Technical Topic Abstracts

606-607, Level 6, Arch at 705 Pike

2:30pm–2:45pmTT053 Establishing and Validating Preanalytical and Contextual Frameworks for Liquid Biopsy: A Collaborative, Iterative BLOODPAC Approach Across BiofluidsUniversity of Washington Medical Center
2:45pm–3:00pmTT030 Clinical Validation and Implementation of RNA Sequencing for the Detection of Medically Relevant Gene FusionsNationwide Children's Hospital
3:00pm–3:15pmTT052 Validation of a Targeted Next-Generation Sequencing Assay for Somatic Variant and Gene Fusion Detection in Cerebrospinal Fluid Liquid BiopsyM.D. Anderson Cancer Center
3:15pm–3:30pmTT004 Semiconductor dPCR HRM with Continuous AI Scoring Enables Robust Tumor Only MSI Detection Across Multiple Cancer TypesSamsung Medical Center

Session

Fri, Nov 13
10:15am–11:45am

Technologist Innovation Session

602-604, Level 6, Arch at 705 Pike

Technical Topics

10:15am–10:35amTT009 Assessment of X-Chromosome Inactivation Using Oxford Nanopore Technologies (ONT) Long-Read SequencingMayo Clinic
10:35am–10:55amID024 Evaluation of a Targeted Metagenomics Kit for Microbial Identification Using the V1-V2 Region of the 16S Ribosomal RNA GeneMayo Clinic
10:55am–11:15amG010 Comparison of Manual Illumina PCR-Free and Hamilton NGS STAR Automated Library Preparation for Germline Whole Genome SequencingToronto General Hospital
11:15am–11:35amH010 Laboratory Developed Test Validation of FL24Cx: A Gene Expression Profiling Assay to Predict Risk of Early Events in Follicular LymphomaUniversity of Arizona

Session

Fri, Nov 13
1:15pm–2:45pm

Clinical Application of Long-read Sequencing

Ballroom E, Level 6, Arch at 705 Pike

Genetics

1:15pm–1:45pmFully Integrated SNV, Fusion, and Isoform Analysis of Cancer Drivers with Long-read RNA-seq for Improved Functional InterpretationUniversity of California, Santa Cruz
1:45pm–2:15pmImproving Long-Read Sequencing for Transcriptome and Amplicon Sequencing ApplicationsUniversity of California, Santa Cruz
2:15pm–2:45pmClinical Implementation of Long-Read Sequencing: From Targeted Assays to Genome SequencingStanford University School of Medicine

Session

Fri, Nov 13
3:45pm–4:45pm

Technical Topics Plenary Session

Ballroom ABC, Level 6, Arch at 705 Pike

Technical Topics

3:45pm–4:45pmStepping Towards Single-Molecule Protein Sequencing Using NanoporesUniversity of Washington

Session

Sat, Nov 14
2:30pm–4:00pm

Technical Advancement in Methylation Profiling

608-609, Level 6, Arch at 705 Pike

Technical Topics

2:30pm–3:00pmBeyond Methylation Classification: The Next Generation of Brain Tumor Diagnostics Through Long-Read Sequencing and Precision OncologyUniversity of Arkansas for Medical Sciences
3:00pm–3:30pmDirect DNA Methylation Analysis by Single Molecule Real-Time SequencingUT MD Anderson Cancer Center
3:30pm–4:00pmBase-Resolution Multiomic Profiling for Rare Cancers and BeyondBroad Clinical Labs

Instantly find 20 buyers from OHSU Knight Cancer Institute

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction